1[1]Davidson B, Goldberg I, Kopolovic J, et al. Expression of matrix metalloproteinase- 9 in squamous cell carcinoma of the uterine cervix [J]. Gynecol oncol, 1999, 72(3): 380- 386.
2[2]Kachra Z, Beaulieu E, Delbecchi L,et al. Expression of matrix metalloproteinaes and their inhibitors in human tumors [J]. Clin Exp metastasis, 1999,17:555- 556.
3[3]Liotta LA, Stetler Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation[J]. Cancer Res ,1991,51:5054- 5059.
4[4]Aznavoorian S, Murphy AN, Stetler Stevenson WG, et al.Molecular aspects of cell invasion and metastasis[J]. Cancer, 1993,71:1368- 1383.
5Nawrocki B, Polette M, Marchand Vet al . Exppression of matrix metallo-proteinase and their inhibitor in human bronchopnlmonary carcinomas:quantificative and morphdogital analyses, Int J Cancer, 1997,72: 556.
6Heppner KJ, Matrisian LM, Jonsen RA et al .Expression of most matrix metalloproteinase family members in breast cancer represonts a tumor induced host response.Am J Pathol, 1996,149:273.
7Yoshikawa T,Saitoh M,Tsuburaya A et al .Tissue inhibitor of matrix metalloprotease-1 in the plasma of patients with gastric carcinoma:a possible marker for serosal invasion and metastasis. Cancer, 1999,86:1929.
8Luparello C, Avanzato G, Carella C et al .Tissue inhibitor of metalloprotease(TIMP-1 ) and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat, 1999,54:235.
9Talvensaari MA, Paakko P, Hoyhtya M et al .Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma.Cancer, 1998,83 : 1153.
6Szabo KA, Singh G.Modulation of monocyte matrix metallopro-teinase-2 by breast adenocarcinoma cells [J]. Breast Cancer Res, 2005, 7 (5): 661-668.
7Jones JL, Glynn P, Walker RA, et al. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1 · MMP in primary breast carcinomas[J]. J Pathol, 1999, 189 (2): 161-168.
8Nakopoulou L, Katsarou S, Giannopoulou I, et al. Corr-elation of tissue inhibitor of metaUoproteinase-2 with proliferative activity and patients' survival in breast cancer [J]. Mod Pathol, 2002, 15 (1): 26-34.
9Li HC, Can DC, Liu Y. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph nodenega- tire breast carci-noma [J]. Breast Cancer Res Treat, 2004, 88 (1) : 75-77.
10Mrena J, Wiksten JP, Nordling S, et al. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer [J]. J Clin Pathol, 2006, 59 (6): 618-623.
